Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Size distribution of cell-free DNA in oncology.

Critical reviews in oncology/hematology - 1 Oct 2021

Udomruk Sasimol, Orrapin Santhasiri, Pruksakorn Dumnoensun, Chaiyawat Parunya

Abstract excerpt

Tumor-specific, circulating cell-free DNA (cfDNA) in liquid biopsy test is a novel promising biomarker in the advancement of cancer management, including early diagnosis, screening, prognosis, identification of actionable targets, and serial tumor monitoring. The specific size pattern of DNA fragments derived from cancer cells is observed to differ from that of cfDNA fragments shed by non-cancer cells. Research...

Topics

Biomarkers, Tumor
Cell-Free Nucleic Acids
Humans
Liquid Biopsy
Medical Oncology
Mutation

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 34464717
DOI: 10.1016/j.critrevonc.2021.103455

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Size distribution of cell-free DNA in oncology.PMID 34464717Read ↗

Cell-Free DNA: Features and Attributes Shaping the Next Frontier in Liquid BiopsySemantic proximity Read ↗

Cell‐free DNA‐associated multi‐feature applications in cancer diagnosis and treatmentSemantic proximity Read ↗

Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoringSemantic proximity Read ↗

Cell-Free DNA Fragmentomics in Liquid BiopsySemantic proximity Read ↗

Cell-free DNA size deconvolution resolves nucleosomal origins and reveals tumor-associated fragmentomic alterations.Semantic proximity Read ↗

Circulating cell-free DNA fragmentation is a stepwise and conserved process linked to apoptosisSemantic proximity Read ↗

Concentration of cell-free DNA in different tumor typesSemantic proximity Read ↗

Size profile of cell-free DNA: A beacon guiding the practice and innovation of clinical testingSemantic proximity Read ↗

Blood has never been thicker: Cell-free DNA fragmentomics in the liquid biopsy toolbox of B-cell lymphomas.Semantic proximity Read ↗

Exploring the Role of Circulating Cell-Free DNA in Disease Diagnosis and TherapySemantic proximity Read ↗

A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.Semantic proximity Read ↗

Diagnostic and Therapeutic Potential of Circulating-Free DNA and Cell-Free RNA in Cancer ManagementSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.